Stockholders' Equity (Cantor Fitzgerald Underwriting and RubrYc Transaction) (Narrative) (Details) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Sep. 19, 2022 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Nov. 25, 2020 |
|
| Subscription receivable | $ 204,000 | |||
| Represents information pertaining to RubrYc Therapeutics, Inc. | ||||
| Sale of preferred stock | $ 1,000,000 | |||
| Number of shares issued | 5,117 | |||
| Sales Agreement | Cantor Fitzgerald [Member] | ||||
| Aggregate offering price | $ 100,000,000 | |||
| Number of shares issued | 170,989 | 289,143 | ||
| Proceeds from sale of shares, net of issuance cost | $ 1,700,000 | $ 6,400,000 | ||
| Subscription receivable | $ 204,000 |
| X | ||||||||||
- Definition The aggregate amount of common shares permitted to be issued by an entity's charter and bylaws. No definition available.
|
| X | ||||||||||
- Definition Amount of subscription receivables classified due within one year or the normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|